Found 2 articles for: "Abrocitinib"
Successful Treatment of Dystrophic Epidermolysis Bullosa With the JAK1 Inhibitor Abrocitinib
April 2026 | Volume 25 | Issue 4 | Case Reports | 384 | Copyright © April 2026
Introduction: JAK inhibitors are increasingly being utilized for the treatment of diseases beyond their nonclassical indications, and thehighly selective JAK1 inhibi...
Read MorePost-Hyaluronic Acid Filler Reaction Treated With Abrocitinib: A Case Report
January 2024 | Volume 23 | Issue 1 | Case Reports | 1355 | Copyright © January 2024
Post-hyaluronic acid filler nodules are uncommon, unpredictable complications that present a challenge to clinical therapy. We report a case of a female in her fifties who developed edema and nod...
Read More
© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.